THE CLINICAL SIGNIFICANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA. Spec. Jour. of Inno. Ref. and Dev. 2024;27:51-58. Accessed January 30, 2026. https://sjird.journalspark.org/index.php/sjird/article/view/1033